Medication info
Lavera M Tablet 20 mg (Rabeprazole Sodium)

Lavera M Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceutical Co., Ltd.
Appearance
Pale yellow round delayed-release film-coated tablets
Packaging
28 tablets / PTP [14 tablets / Alu-Alu packaging x 2]
Approval status
Active

MFDS item code 201908081 · Approved 2019.11.26 · Insurance code 641502590

Summary

Main use
Treatment of gastroesophageal reflux disease, gastrointestinal ulcers (e.g., in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If treatment has not resolved the condition after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily should be used only in patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled with on-demand therapy using 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to individual patient needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Ingredients

Manufacturer
McNulty Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, gastrointestinal ulcers (e.g., in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease symptoms
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat ulcers that occur in the stomach and duodenum. It also alleviates the symptoms of gastroesophageal reflux disease, such as reflux esophagitis and aids in long-term treatment. It is used together with antibiotics to enhance therapeutic effects for patients with gastrointestinal ulcers caused by Helicobacter pylori infection. Additionally, although rare, it is also utilized for Zollinger-Ellison syndrome caused by excessive gastric acid secretion. In summary, this medication is effective in improving both the symptoms and causes of various gastrointestinal-related diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If treatment has not resolved the condition after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily should be used only in patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled with on-demand therapy using 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to individual patient needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Precautions

This medication should not be used in patients with certain allergic reactions or those who have had allergic symptoms to this drug or similar medications in the past. Additionally, it is contraindicated for patients who are taking certain antibiotics or other medications, and for pregnant or nursing women. Care should be taken when using this medicine in patients with liver function problems or the elderly. Patients with a history of allergies should be administered with caution. If allergic symptoms such as skin rash or itching appear during the intake of this medicine, the patient should stop taking it immediately and consult a healthcare professional. Regular blood tests are recommended as abnormal results may occur. Liver function tests should be continuously monitored and drug administration should be discontinued if abnormalities are found. Caution is necessary if cardiovascular symptoms occur, as it may affect the heart or blood pressure. Gastrointestinal symptoms may appear; therefore, if symptoms such as abdominal pain, diarrhea, or vomiting persist, the patient should inform healthcare professionals. Mental symptoms or neurological abnormalities such as headaches, dizziness, and insomnia may occur, and if severe, the patient should consult a doctor. Respiratory symptoms or, rarely, serious lung diseases may appear, so if severe shortness of breath or worsening cough occurs, the patient should inform healthcare professionals immediately. Various side effects such as muscle pain, joint pain, skin rash, and hair loss have been reported; hence, the patient's condition should be closely monitored. Abnormal symptoms related to the eyes or ears may also occur, so if there are changes in vision or hearing, it is advisable to report them. Abnormal urinary tract symptoms or genital bleeding have also been reported, so if such symptoms occur, the patient should consult healthcare professionals. Long-term use may increase the risk of fractures, and regular evaluations are necessary if taking for an extended period. Electrolyte abnormalities like hypomagnesemia may occur, so if taking for a long time or with certain medications, magnesium levels should be checked regularly. Since this drug strongly inhibits gastric acid secretion, there may be a slightly increased risk of bacterial infections in the stomach, so if diarrhea persists or is severe, it should be reported to healthcare professionals. Caution is advised while driving or operating machinery due to possible drowsiness. Interactions may occur when this drug is combined with certain medications, so if other medications are being taken, it is essential to inform healthcare professionals. It is safest to avoid this drug during pregnancy or while nursing. Elderly patients may experience side effects due to decreased liver function; therefore, drug administration should be adjusted or discontinued if symptoms occur. Safety in pediatric patients has not been established, thus its use is not recommended. There is no specific antidote for overdose; appropriate treatment should be provided based on the symptoms. This medication should be swallowed whole and not chewed or crushed, and it should be kept out of reach of children. Regular check-ups and consultations with healthcare professionals are essential for safe management during long-term use.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thromboembolic venous disease, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulceration, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenopathy, thirst, headache, insomnia, anxiety, dizziness, convulsion, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased blood volume, weakness of the limbs, sensory deficits, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonic muscular hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, urinary frequency, dysmenorrhea, urinary difficulty, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, incontinence, interstitial nephritis, edema, total cholesterol elevation, triglyceride elevation, BUN elevation, serum thyroid-stimulating hormone elevation, chest pain, chills, fever, urinary tract infection, erythema, malaise, weight gain, visual disturbance, anorexia, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, arthralgia, interstitial nephritis, gynecomastia, thyroid-stimulating hormone elevation, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Avoid excessively hot or cold places and store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pale yellow round delayed-release film-coated tablets

Package unit

28 tablets / PTP [14 tablets / Alu-Alu packaging x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.